US approves updated Pfizer, Moderna shots targeting Omicron / Photo: Joseph Prezioso - AFP/File
-
Palmeiras v Al Ahly Club World Cup clash suspended for weather
-
French Open winner Gauff falls at first hurdle on Berlin grass
-
Cleanup begins as Hurricane Erick moves on from Mexican coast
-
Restoration rejuvenates iconic Gaudi house in Barcelona
-
France softens restrictions for Telegram founder Durov
-
Trump 'Golden Dome' plan tricky and expensive: experts
-
French state leads capital increase for satellite operator Eutelsat
-
Russia steps out from shadows in Africa with state paramilitary
-
Trawlerman and Buick move into top gear to land Ascot Gold Cup
-
France softens restrictions for Telegram founder Durov: judicial source
-
Trump extends deadline for TikTok sale by 90 days
-
Indonesia leader touts growing Russia ties after talks with Putin
-
Czech champion Kvitova calls time on tennis career
-
Test series win in England bigger prize than IPL, says India captain Gill
-
Sabalenka back to winning ways in Berlin
-
Mahuchikh, Holloway headline Paris Diamond League
-
How did life survive 'Snowball Earth'? In ponds, study suggests
-
Russell signs new deal at Premiership champions Bath
-
2,000-year-old Roman wall paintings unearthed in London
-
Tourists, fishermen hunker as Hurricane Erick pounds Mexican coast
-
How Trumponomics has shaken global markets
-
Sabalenka back to winnings ways in Berlin
-
Real Madrid star Mbappe hospitalised with stomach bug
-
Dropping Pope for India Test would have been 'remarkable', says England's Stokes
-
Climate change could double summer rainfall in the Alps: study
-
If Iran's Khamenei falls, what would replace him?
-
India's Bumrah aiming for three Tests out of five against England
-
Mutilation ban and microchips: EU lawmakers approve cat and dog welfare rules
-
Israel minister says Iran leader 'can no longer exist' after hospital hit
-
Thai PM clings on as crisis threatens to topple government
-
Govts scramble to evacuate citizens from Israel and Iran
-
Floods expected after Hurricane Erick makes landfall in western Mexico
-
Russia warns US against 'military intervention' in Iran-Israel war
-
Budapest mayor defies police ban on Pride march
-
Air India says plane 'well-maintained' before crash
-
Arctic warming spurs growth of carbon-soaking peatlands
-
Swiss central bank cuts interest rates to zero percent
-
Bordeaux-Begles 'underdogs' before Top 14 semis despite Champions Cup triumph
-
Gattuso convinced Italy can reach World Cup
-
Relieved Pakistanis recall 'horrifying nights' as Israel, Iran trade strikes
-
England v India: Three key battles
-
Stocks drop, oil gains as Mideast unrest fuels inflation fears
-
Israel's Netanyahu says Iran will 'pay heavy price' after hospital hit
-
France steps closer to defining rape as lack of consent
-
SpaceX Starship explodes during routine test
-
Belgrade show plots path out of Balkan labyrinth of pain
-
Thailand's 'Yellow Shirts' return to streets demand PM quit
-
Stocks drop after Fed comments as Mideast fears lift crude
-
Govts scramble to evacuate citizens from Israel, Iran
-
'Moving Great Wall': China unleash towering teen basketball star
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
K.Hassan--SF-PST
